Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Overexpressing SERCA2a via gene therapy represents a promising approach to reduce ischemia-reperfusion injury and arrhythmias, though translation from rodent models to humans requires caution due to differences in calcium cycling and potential proarrhythmic risks.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: